WHO cheers COVID-19 trial results of dexamethasone
World Health Organization Director-General Tedros Adhanom Ghebreyesus on Tuesday called the initial clinical trial results of a steroid shown to reduce deaths in critically ill coronavirus patients “great news.”
“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” he said of dexamethasone, which reduced the mortality of those on ventilators in the trial by one-third.
“However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient. Future strategies should evaluate antiviral agents in combination with other therapeutic approaches or combinations of antiviral agents to continue to improve patient outcomes in COVID-19.”
I’ve been posting about the fiasco of fake HCQ studies but despite these flawed and biased studies, the FDA stopped the EUA for HCQ. Now the AAPS is suing the FDA over it: https://madisonarealymesupportgroup.com/2020/06/16/aaps-sues-fda-for-irrational-interference-of-access-to-life-saving-hydroxychloroquine/
- https://madisonarealymesupportgroup.com/2020/05/22/new-study-hcq-zinc-greatly-reduces-covid-19-health-risk/
- https://madisonarealymesupportgroup.com/2020/06/09/hcq-breakthrough-icmr-finds-its-effective-in-preventing-coronavirus-expands-its-use/
Doctors continue to state that it is a lifesaver for a subset of patients, is safe, and inexpensive, but nobody seems to care about the experience of clinical doctors.
According to Kory, the FLCCCs MATH+ protocol has been delivered to the White House on four occasions, yet no interest has been shown. Worse, he says they continue to be stonewalled by the U.S. Centers for Disease Control and the National Institute for Health. Why?
Isn’t saving lives, right now, and by any means possible, more important than pushing for a vaccine? If the MATH+ protocol works with near-100% effectiveness, a vaccine may not even be necessary.The MATH+ protocol gets its name from:
|
